{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:22:31Z","timestamp":1783506151789,"version":"3.55.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100018896","name":"Sylvester Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014454","name":"University of Miami Miller School of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014454","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NCI Cancer Center Support Grant","award":["P30-CA240139"],"award-info":[{"award-number":["P30-CA240139"]}]},{"name":"NCI Cancer Center Support Grant","award":["R01CA265999"],"award-info":[{"award-number":["R01CA265999"]}]},{"name":"NCI Cancer Center Support Grant","award":["R01CA276082"],"award-info":[{"award-number":["R01CA276082"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Activation of Rac1, a member of the Rho family of small GTPases and a well-established downstream effector of receptor tyrosine kinases (RTKs), has been linked to prostate cancer progression and predicts poor progression in prostate cancer patients. Rac1 and its upstream activators, the Rac guanine nucleotide exchange factors (Rac-GEFs), act as key drivers for RTK-mediated formation of actin-rich protrusions, structures involved in cancer cell motility and invasion. Our previous study identified VAV2 as the main Rac-GEF effector of epidermal growth factor receptor in androgen-independent cellular models. An unbiased RNAi screen targeting Rac-GEFs as effectors of cMET, which is an RTK frequently overexpressed in castration-resistant prostate cancer and associated with invasion and metastasis, identified the Rac-GEF FARP1 (FERM, ARH\/RhoGEF and Plekstrin Domain Protein 1) as a pivotal contributor to Rac1-mediated migration and invasion. Notably, stimulation of cMET with its ligand Hepatocyte Growth Factor (HGF) promotes the formation of actin-rich protrusions through a PI3K-FARP1-Rac1-dependent pathway and independently of VAV2. Furthermore, FARP1 relocalizes to actin-rich protrusions in PC3 cells in response to HGF stimulation. Our results shed light on the distinctive contribution of Rac-GEFs to prostate cancer cell motility via RTKs and identify FARP1 as a crucial cMET-invasive effector. The differential coupling of RTKs to Rac-GEFs underscores the complexities of signaling events leading to Rac1 activation. It provides insight into the RTK effectors that contribute to prostate cancer cell invasiveness.<\/jats:p>","DOI":"10.1210\/endocr\/bqag062","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:50:12Z","timestamp":1779450612000},"source":"Crossref","is-referenced-by-count":0,"title":["FARP1 mediates cMET-driven motility in androgen-independent prostate cancer cells"],"prefix":"10.1210","volume":"167","author":[{"given":"Paola","family":"Robayo","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-017X","authenticated-orcid":false,"given":"Marcelo G","family":"Kazanietz","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]},{"name":"Sylvester Comprehensive Cancer Center, University of Miami , Miami, FL 33136 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Baker","sequence":"additional","affiliation":[{"name":"Manchester Cancer Research Centre (MCRC), Division of Cancer Sciences, University of Manchester , Manchester M20 4GJ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-8447","authenticated-orcid":false,"given":"Mariana","family":"Cooke","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]},{"name":"Sylvester Comprehensive Cancer Center, University of Miami , Miami, FL 33136 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"1","key":"2026070806120465100_bqag062-B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"26","key":"2026070806120465100_bqag062-B2","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2-3","key":"2026070806120465100_bqag062-B3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10555-013-9475-z","article-title":"Growth factor and signaling pathways and their relevance to prostate cancer therapeutics","volume":"33","author":"Wozney","year":"2014","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"2026070806120465100_bqag062-B4","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/sj.bjc.6605376","article-title":"Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth","volume":"101","author":"Traish","year":"2009","journal-title":"Br J Cancer"},{"issue":"21","key":"2026070806120465100_bqag062-B5","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-13-1550","article-title":"Targeting fibroblast growth factor pathways in prostate cancer","volume":"19","author":"Corn","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"52","key":"2026070806120465100_bqag062-B6","doi-asserted-by":"crossref","first-page":"20123","DOI":"10.1074\/jbc.RA118.005395","article-title":"Activation of hepatocyte growth factor\/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate","volume":"293","author":"Mi","year":"2018","journal-title":"J Biol Chem"},{"key":"2026070806120465100_bqag062-B7","doi-asserted-by":"crossref","first-page":"1071030","DOI":"10.3389\/fonc.2023.1071030","article-title":"Targeting c-Met in the treatment of urologic neoplasms: current status and challenges","volume":"13","author":"Su","year":"2023","journal-title":"Front Oncol"},{"issue":"12","key":"2026070806120465100_bqag062-B8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1517\/13543784.2011.631523","article-title":"The role of HGF\/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials","volume":"20","author":"Varkaris","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"2026070806120465100_bqag062-B9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/1471-2407-10-556","article-title":"Efficacy of c-Met inhibitor for advanced prostate cancer","volume":"10","author":"Tu","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"2026070806120465100_bqag062-B10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9440(10)63318-4","article-title":"Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R","volume":"165","author":"Nakashiro","year":"2004","journal-title":"Am J Pathol"},{"issue":"3","key":"2026070806120465100_bqag062-B11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/0008-5472.CAN-06-3552","article-title":"The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression","volume":"67","author":"Verras","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"2026070806120465100_bqag062-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2015.11.009","article-title":"Mechanistic support for combined MET and AR blockade in castration-resistant prostate cancer","volume":"18","author":"Qiao","year":"2016","journal-title":"Neoplasia"},{"issue":"5","key":"2026070806120465100_bqag062-B13","first-page":"401","article-title":"New insights into the formation and the function of lamellipodia and ruffles in mesenchymal cell migration","volume":"12","author":"Innocenti","year":"2018","journal-title":"Cell Adh Migr"},{"issue":"20","key":"2026070806120465100_bqag062-B14","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1158\/0008-5472.CAN-17-1456","article-title":"The Rac GTPase in cancer: from old concepts to new paradigms","volume":"77","author":"Kazanietz","year":"2017","journal-title":"Cancer Res"},{"issue":"4","key":"2026070806120465100_bqag062-B15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1042\/BST20170519","article-title":"The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic","volume":"46","author":"Casado-Medrano","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"2026070806120465100_bqag062-B16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fcell.2020.00118","article-title":"Rac-GEF\/Rac signaling and metastatic dissemination in lung cancer","volume":"8","author":"Cooke","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2026070806120465100_bqag062-B17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/cancers12020480","article-title":"P-REX1-independent, calcium-dependent RAC1 hyperactivation in prostate cancer","volume":"12","author":"Baker","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"40","key":"2026070806120465100_bqag062-B18","doi-asserted-by":"crossref","first-page":"13698","DOI":"10.1074\/jbc.RA120.013919","article-title":"Evaluation of active Rac1 levels in cancer cells: a case of misleading conclusions from immunofluorescence analysis","volume":"295","author":"Baker","year":"2020","journal-title":"J Biol Chem"},{"issue":"8","key":"2026070806120465100_bqag062-B19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1541-7786.MCR-24-0957","article-title":"VAV2 drives EGFR-mediated Rac1 responses in prostate cancer","volume":"23","author":"Baker","year":"2025","journal-title":"Mol Cancer Res"},{"key":"2026070806120465100_bqag062-B20","doi-asserted-by":"crossref","first-page":"1658639","DOI":"10.3389\/fcell.2025.1658639","article-title":"RAC1 signaling in prostate cancer: VAV GEFs take center stage","volume":"13","author":"Cooke","year":"2025","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"2026070806120465100_bqag062-B21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.tcb.2022.06.003","article-title":"Nonredundant Rac-GEF control of actin cytoskeleton reorganization","volume":"32","author":"Kazanietz","year":"2022","journal-title":"Trends Cell Biol"},{"issue":"5","key":"2026070806120465100_bqag062-B22","doi-asserted-by":"crossref","first-page":"109905","DOI":"10.1016\/j.celrep.2021.109905","article-title":"FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma","volume":"37","author":"Cooke","year":"2021","journal-title":"Cell Rep"},{"issue":"22","key":"2026070806120465100_bqag062-B23","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1074\/jbc.RA117.000235","article-title":"Characterization of AJH-836, a diacylglycerol-lactone with selectivity for novel PKC isozymes","volume":"293","author":"Cooke","year":"2018","journal-title":"J Biol Chem"},{"key":"2026070806120465100_bqag062-B24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-0716-1190-6_7","article-title":"Active GTPase pulldown protocol","volume":"2262","author":"Baker","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2026070806120465100_bqag062-B25","doi-asserted-by":"crossref","first-page":"101437","DOI":"10.1016\/j.xpro.2022.101437","article-title":"Quantification of ruffle area and dynamics in live or fixed lung adenocarcinoma cells","volume":"3","author":"Kreider-Letterman","year":"2022","journal-title":"STAR Protoc"},{"key":"2026070806120465100_bqag062-B26","unstructured":"Robayo P, Kazanietz MG, Baker MJ, et al \u00a02026. Supplemental Material. figshare. Figure. 10.6084\/m9.figshare.32038539."},{"issue":"19","key":"2026070806120465100_bqag062-B27","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.1074\/jbc.M113.527556","article-title":"Role of c-Met\/phosphatidylinositol 3-kinase (PI3k)\/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells","volume":"289","author":"Usatyuk","year":"2014","journal-title":"J Biol Chem"},{"issue":"7","key":"2026070806120465100_bqag062-B28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1083\/jcb.149.7.1419","article-title":"Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses","volume":"149","author":"Schaeper","year":"2000","journal-title":"J Cell Biol"},{"issue":"2","key":"2026070806120465100_bqag062-B29","first-page":"386","article-title":"Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma","volume":"147","author":"Humphrey","year":"1995","journal-title":"Am J Pathol"},{"issue":"3","key":"2026070806120465100_bqag062-B30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1442-2042.1998.tb00603.x","article-title":"Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor","volume":"5","author":"Nishimura","year":"1998","journal-title":"Int J Urol"},{"issue":"2","key":"2026070806120465100_bqag062-B31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/21541248.2014.973757","article-title":"Vav family exchange factors: an integrated regulatory and functional view","volume":"5","author":"Bustelo","year":"2014","journal-title":"Small GTPases"},{"issue":"1","key":"2026070806120465100_bqag062-B32","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1038\/s41598-018-28692-4","article-title":"Structural analyses of FERM domain-mediated membrane localization of FARP1","volume":"8","author":"Kuo","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"2026070806120465100_bqag062-B33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.str.2013.01.001","article-title":"Structural basis for autoinhibition of the guanine nucleotide exchange factor FARP2","volume":"21","author":"He","year":"2013","journal-title":"Structure"},{"issue":"8","key":"2026070806120465100_bqag062-B34","doi-asserted-by":"publisher","first-page":"104983","DOI":"10.1016\/j.jbc.2023.104983","article-title":"Gi\/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a G\u03b2\u03b3\/PKC\u03b1\/FARP1\/Cdc42 axis","volume":"299","author":"Cooke","year":"2023","journal-title":"J Biol Chem"},{"issue":"2","key":"2026070806120465100_bqag062-B35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-020-0190-7","article-title":"FARP1 boosts CDC42 activity via integrin \u03b1v\u03b25 signaling and correlates with a poor prognosis in advanced gastric cancer","volume":"9","author":"Hirano","year":"2020","journal-title":"Oncogenesis"},{"key":"2026070806120465100_bqag062-B36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fcell.2020.00201","article-title":"Targeting Rac and Cdc42 GEFs in metastatic cancer","volume":"8","author":"Maldonado","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2026070806120465100_bqag062-B37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/21541248.2016.1211398","article-title":"Rac1 in human diseases: the therapeutic potential of targeting Rac1 signaling regulatory mechanisms","volume":"8","author":"Marei","year":"2017","journal-title":"Small GTPases"},{"issue":"3","key":"2026070806120465100_bqag062-B38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41375-021-01455-3","article-title":"Inhibition of the RacGEF VAV3 by the small-molecule inhibitor IODVA1 impairs RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia","volume":"36","author":"Hegde","year":"2022","journal-title":"Leukemia"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag062\/68373146\/bqag062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/7\/bqag062\/68373146\/bqag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/7\/bqag062\/68373146\/bqag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:12:22Z","timestamp":1783505542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag062\/8691254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag062","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,23]]},"article-number":"bqag062"}}